InMode Ltd. (NASDAQ:INMD - Get Free Report)'s stock price hit a new 52-week low on Monday . The company traded as low as $14.56 and last traded at $14.62, with a volume of 173240 shares traded. The stock had previously closed at $15.71.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on the company. Barclays raised their target price on InMode from $26.00 to $29.00 and gave the company an "overweight" rating in a research note on Wednesday, February 5th. Needham & Company LLC reaffirmed a "hold" rating on shares of InMode in a research note on Wednesday. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $22.25.
View Our Latest Report on INMD
InMode Stock Up 5.5 %
The company has a market capitalization of $1.04 billion, a price-to-earnings ratio of 6.33 and a beta of 1.96. The business has a 50-day moving average price of $18.01 and a 200-day moving average price of $17.67.
Institutional Trading of InMode
Hedge funds have recently bought and sold shares of the company. GAMMA Investing LLC lifted its position in shares of InMode by 13,923.8% in the 1st quarter. GAMMA Investing LLC now owns 2,945 shares of the healthcare company's stock valued at $520,000 after acquiring an additional 2,924 shares in the last quarter. Orion Capital Management LLC purchased a new stake in shares of InMode in the fourth quarter valued at $65,000. SBI Securities Co. Ltd. acquired a new stake in shares of InMode in the fourth quarter worth $87,000. Farther Finance Advisors LLC grew its holdings in shares of InMode by 26.2% during the fourth quarter. Farther Finance Advisors LLC now owns 5,555 shares of the healthcare company's stock valued at $93,000 after buying an additional 1,154 shares in the last quarter. Finally, Covestor Ltd raised its position in InMode by 13.9% during the fourth quarter. Covestor Ltd now owns 5,936 shares of the healthcare company's stock valued at $99,000 after buying an additional 723 shares during the period. 68.04% of the stock is owned by hedge funds and other institutional investors.
About InMode
(
Get Free Report)
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
Read More
Before you consider InMode, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InMode wasn't on the list.
While InMode currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
